Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Nagren, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Langer, O; Dolle, F; Valette, H; Halldin, C; Vaufrey, F; Fuseau, C; Coulon, C; Ottaviani, M; Nagren, K; Bottlaender, M; Maziere, B; Crouzel, C
      Synthesis of high-specific-radioactivity 4- and 6-[F-18]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart

      BIOORGANIC & MEDICINAL CHEMISTRY
    2. Holopainen, IE; Metsahonkala, EL; Kokkonen, H; Parkkola, RK; Manner, TE; Nagren, K; Korpi, ER
      Decreased binding of [C-11]flumazenil in Angelman syndrome patients with GABA(A) receptor beta(3) subunit deletions

      ANNALS OF NEUROLOGY
    3. Sutinen, E; Jyrkkio, S; Gronroos, T; Haaparanta, M; Lehikoinen, P; Nagren, K
      Biodistribution of [C-11]methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    4. Ukkonen, H; Knuuti, J; Katoh, C; Iida, H; Sipila, H; Lehikoinen, P; Nagren, K; Voipio-Pulkki, LM
      Use of [C-11]acetate and [O-15]O-2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    5. Pietila, M; Malminiemi, K; Ukkonen, H; Saraste, M; Nagren, K; Lehikoinen, P; Volpio-Pulkki, LM
      Reduced myocardial carbon-11 hydroxyephedrine retention is associated withpoor prognosis in chronic heart failure

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    6. Knuuti, J; Takala, TO; Nagren, K; Sipila, H; Turpeinen, AK; Uusitupa, MIJ; Nuutila, P
      Myocardial fatty acid oxidation in patients with impaired glucose tolerance

      DIABETOLOGIA
    7. Kaasinen, V; Nagren, K; Hietala, J; Farde, L; Rinne, JO
      Sex differences in extrastriatal dopamine D-2-like receptors in the human brain

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Langer, O; Halldin, C; Chou, YH; Sandell, J; Swahn, CG; Nagren, K; Perrone, R; Berardi, F; Leopoldo, M; Farde, L
      Carbon-11 PB-12: An attempt to visualize the dopamine D-4 receptor in the primate brain with positron emission tomography

      NUCLEAR MEDICINE AND BIOLOGY
    9. Oikonen, V; Allonen, T; Nagren, K; Kajander, J; Hietala, J
      Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum

      NUCLEAR MEDICINE AND BIOLOGY
    10. Krasikova, R; Fedorova, O; Korsakov, M; Nagren, K; Maziere, B; Halldin, C
      A fast and convenient method for robotic preparation of [C-11]flumazenil avoiding HPLC purification

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    11. Kamarainen, EL; Kyllonen, T; Airaksinen, A; Lundkvist, C; Yu, MX; Nagren, K; Sandell, J; Langer, O; Vepsalainen, J; Hiltunen, J; Bergstrom, K; Lotjonen, S; Jaakkola, T; Halldin, C
      Preparation of [F-18]beta-CFT-FP and [C-11]beta-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET)

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    12. Nagren, K; Sutinen, E; Jyrkkio, S
      [N-methyl-C-11]MeAIB, a tracer for system A amino acid transport: Preparation from [C-11]methyl triflate and HPLC metabolite analysis of plasma samples after intravenous administration in man.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    13. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
      Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    14. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    15. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    16. Kemppainen, N; Ruottinen, H; Nagren, K; Rinne, JO
      PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD

      NEUROLOGY
    17. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
      Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

      NEUROLOGY
    18. Lamusuo, S; Pitkanen, A; Jutila, L; Ylinen, A; Partanen, K; Kalviainen, R; Ruottinen, HM; Oikonen, V; Nagren, K; Lehikoinen, P; Vapalahti, M; Vainio, P; Rinne, JO
      [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology

      NEUROLOGY
    19. Ukkonen, H; Saraste, M; Akkila, J; Knuuti, J; Karanko, M; Iida, H; Lehikoinen, P; Nagren, K; Lehtonen, L; Voipio-Pulkki, LM
      Myocardial efficiency during levosimendan infusion in congestive heart failure

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Pohjalainen, T; Nagren, K; Syvalahti, EKG; Hietala, J
      The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo

      PHARMACOGENETICS
    21. Langer, O; Nagren, K; Dolle, F; Lundkvist, C; Sandell, J; Swahn, CG; Vaufrey, F; Crouzel, C; Maziere, B; Halldin, C
      Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    22. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
      Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    23. Vesalainen, RK; Pietila, M; Tahvanainen, KUO; Jartti, T; Teras, M; Nagren, K; Lehikoinen, P; Huupponen, R; Ukkonen, H; Saraste, M; Knuuti, J; Voipio-Pulkki, LM
      Cardiac positron emission tomography imaging with [C-11]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

      AMERICAN JOURNAL OF CARDIOLOGY
    24. Kanerva, H; Vilkman, H; Nagren, K; Kilkku, O; Kuoppamaki, M; Syvalahti, E; Hietala, J
      Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study

      PSYCHOPHARMACOLOGY
    25. POHJALAINEN T; RINNE JO; NAGREN K; LEHIKOINEN P; ANTTILA K; SYVALAHTI EKG; HIETALA J
      THE A1 ALLELE OF THE HUMAN D-2 DOPAMINE-RECEPTOR GENE PREDICTS LOW D-2 RECEPTOR AVAILABILITY IN HEALTHY-VOLUNTEERS

      Molecular psychiatry
    26. KAJANDER J; VILKMAN H; SYVALAHTI E; NAGREN K; HIETALA J
      EFFECTS OF REPEATED FLUOXETINE TREATMENT ON STRIATAL D-2 DOPAMINE BINDING IN HUMANS, MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY

      Nordic journal of psychiatry
    27. NAGREN K; HALLDIN C
      METHYLATION OF AMIDE AND THIOL FUNCTIONS WITH [C-11] METHYL TRIFLATE,AS EXEMPLIFIED BY [C-11] NMSP, [C-11] FLUMAZENIL AND [C-11] METHIONINE

      Journal of labelled compounds & radiopharmaceuticals
    28. LUNDKVIST C; SANDELL J; NAGREN K; PIKE VW; HALLDIN C
      IMPROVED SYNTHESES OF THE PET RADIOLIGANDS, [C-11] FLB457, [C-11] MDL100907 AND [C-11] BETA-CIT-FE, BY THE USE OF [C-11] METHYL TRIFLATE

      Journal of labelled compounds & radiopharmaceuticals
    29. NUUTINEN J; LESKINEN S; LINDHOLM P; SODERSTROM KO; NAGREN K; HUHTALA S; MINN H
      USE OF C-11 METHIONINE POSITRON-EMISSION-TOMOGRAPHY TO ASSESS MALIGNANCY GRADE AND PREDICT SURVIVAL IN PATIENTS WITH LYMPHOMAS

      European journal of nuclear medicine
    30. RINNE JO; SAHLBERG N; RUOTTINEN H; NAGREN K; LEHIKOINEN P
      STRIATAL UPTAKE OF THE DOPAMINE REUPTAKE LIGAND [C-11] BETA-CFT IS REDUCED IN ALZHEIMERS-DISEASE ASSESSED BY POSITRON-EMISSION-TOMOGRAPHY

      Neurology
    31. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
      SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO

      The American journal of psychiatry
    32. SALONEN I; HIETALA J; LAIHINEN A; LEHIKOINEN P; LEINO L; NAGREN K; RUOTSALAINEN U; OIKONEN V; TUOKKOLA T; NANTO V
      A PET STUDY ON THE ACUTE EFFECT OF ETHANOL ON STRIATAL D2 DOPAMINE-RECEPTORS WITH [C-11] RACLOPRIDE IN HEALTHY-MALES

      Human psychopharmacology
    33. LANGER O; DOLLE F; LOCH C; HALLDIN C; VAUFREY F; COULON C; CROUZEL C; NAGREN K; MAZIERE B
      PREPARATION OF 4-[BR-76]BROMOMETARAMINOL AND 6-[BR-76]BROMOMETARAMINOL, 2 POTENTIAL RADIOTRACERS FOR THE STUDY OF THE MYOCARDIAL NOREPINEPHRINE NEURONAL REUPTAKE SYSTEM WITH PET

      Journal of labelled compounds & radiopharmaceuticals
    34. LESKINEN S; PULKKI K; KNUUTI J; KIRVELA O; LEHIKOINEN P; NAGREN K; RUOTSALAINEN U; TERAS M; WEGELIUS U; SALMINEN E
      TRANSPORT OF CARBON-11-METHIONINE IS ENHANCED BY INSULIN

      The Journal of nuclear medicine
    35. UKKONEN H; SARASTE M; AKKILA J; KNUUTI MJ; LEHIKOINEN P; NAGREN K; LEHTONEN L; VOIPIOPULKKI LM
      MYOCARDIAL EFFICIENCY DURING CALCIUM SENSITIZATION WITH LEVOSIMENDAN - A NONINVASIVE STUDY WITH POSITRON EMISSION TOMOGRAPHY AND ECHOCARDIOGRAPHY IN HEALTHY-VOLUNTEERS

      Clinical pharmacology and therapeutics
    36. PIETILA MJ; UKKONEN H; SARASTE M; NAGREN K; LEHIKOINEN P; KNUUTI J; VOIPIOPULKKI LM
      EXERCISE TRAINING IMPROVES MYOCARDIAL SYMPATHETIC INNERVATION AND MAYIMPROVE REDUCED MYOCARDIAL BLOOD FLAW IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - A PET STUDY

      Circulation
    37. POHJALAINEN T; CRAVCHIK A; GEJMAN PV; RINNE J; NAGREN K; SYVALAHTI E; HIETALA J
      ANTAGONIST BINDING CHARACTERISTICS OF THE SER(311)-]CYS VARIANT OF HUMAN DOPAMINE D-2 RECEPTOR IN-VIVO AND IN-VITRO

      Biochemical and biophysical research communications
    38. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI EKG; PELTONEN L; HIETALA J
      HUMAN D-2 DOPAMINE-RECEPTOR GENE POLYMORPHISMS AND BINDING CHARACTERISTICS IN-VIVO

      American journal of human genetics
    39. HIETALA J; KUOPPAMAKI M; NAGREN K; LEHIKOINEN P; SYVALAHTI E
      EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY

      Psychopharmacology
    40. NAGREN K; HALLDIN C; SWAHN CG; SUHARA T; FARDE L
      [C-11] METARAMINOL, A FALSE NEUROTRANSMITTER - PREPARATION, METABOLITE STUDIES AND POSITRON EMISSION TOMOGRAPHY EXAMINATION IN MONKEY

      Nuclear medicine and biology
    41. RINNE JO; HUBLIN C; PARTINEN M; RUOTTINEN H; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; LAIHINEN A
      STRIATAL DOPAMINE D-1 RECEPTORS IN NARCOLEPSY - A PET STUDY WITH [C-11]NNC-756

      Journal of sleep research
    42. LINDHOLM P; LAPELA M; LESKINEN S; NAGREN K; LEHIKOINEN P; WEGELIUS U; NORDMAN E
      EVALUATION OF EARLY RESPONSE TO THERAPY IN ADVANCED BREAST-CANCER BY 11C-METHIONINE PET

      The Journal of nuclear medicine
    43. UKKONEN HJ; SARASTE M; AKKILA JH; KNUUTI J; LEHIKOINEN P; NAGREN K; LEHTONEN LA; VOIPIOPULKKI LM
      ENERGETICAL EFFECTS OF LEVOSIMENDAN IN CONGESTIVE-HEART-FAILURE AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY

      Circulation
    44. TIIHONEN J; KUOPPAMAKI M; NAGREN K; BERGMAN J; ERONEN E; SYVALAHTI E; HIETALA J
      SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY

      Psychopharmacology
    45. NAGREN K; HALLDIN C; MULLER L; SWAHN CG; LEHIKOINEN P
      COMPARISON OF [C-11] METHYL TRIFLATE AND [C-11] METHYL-IODIDE IN THE SYNTHESIS OF PET RADIOLIGANDS SUCH AS [C-11] BETA-CIT AND [C-11] BETA-CFT

      Nuclear medicine and biology
    46. NAGREN K; HALLDIN C; SWAHN CG; SCHOEPS KO; LANGER O; MITTERHAUSER M; ZOLLE I
      SOME NEW METHODS FOR THE SYNTHESIS OF CARDIAC NEUROTRANSMISSION PET RADIOTRACERS

      Nuclear medicine and biology
    47. SWAHN CG; HALLDIN C; NAGREN K; FARDE L
      AN HPLC-METHOD FOR DETERMINATION OF LIGAND METABOLISM DURING PET STUDIES WITH [C-11] METARAMINOL AND [C-11] NOREPINEPHRINE

      Nuclear medicine and biology
    48. FARDE L; HALLDIN C; NAGREN K; KARLSSON P; SWAHN CG; SUHARA T
      PET EXAMINATION OF THE MONKEY HEART WITH HIGH SPECIFIC RADIOACTIVITY [C-11] NOREPINEPHRINE AND [C-11] METARAMINOL

      Nuclear medicine and biology
    49. NAGREN K; MULLER L; HALLDIN C; SWAHN CG; LEHIKOINEN P
      IMPROVED SYNTHESIS OF SOME COMMONLY USED PET RADIOLIGANDS BY THE USE OF [C-11] METHYL TRIFLATE

      Nuclear medicine and biology
    50. LESKINEN S; KIRVELA O; KNUUTI J; LEHIKOINEN P; NAGREN K; PULKKI K; RUOTSALAINEN U; TERAS M; WEGELIUS U; NORDMAN E
      INSULIN-RESISTANCE IN AMINO-ACID-TRANSPORT SYSTEM-A IN HEAD AND NECK-CANCER PATIENTS STUDIED BY POSITRON EMISSION TOMOGRAPHY (PET) AND C-11-METHIONINE

      European journal of cancer
    51. LINDHOLM P; LESKINEN S; JOENSUU H; LEHIKOINEN P; NAGREN K; TERAS M; RUOTSALAINEN U; WEGELIUS U; NORDMAN E
      POSITRON EMISSION TOMOGRAPHY AND CARBON-11-METHIONINE FOR ASSESSING RESPONSE TO RADIOTHERAPY IN CANCER OF THE ORAL CAVITY AND LARYNX - PRELIMINARY-RESULTS

      European journal of cancer
    52. RINNE JO; LAIHINEN A; NAGREN K; RUOTTINEN H; RUOTSALAINEN U; RINNE UK
      PET EXAMINATION OF THE MONOAMINE TRANSPORTER WITH [C-11] BETA-CIT AND[C-11] BETA-CFT IN EARLY PARKINSONS-DISEASE

      Synapse
    53. LINDHOLM P; LESKINENKALLIO S; GRENMAN R; LEHIKOINEN P; NAGREN K; TERAS M; RUOTSALAINEN U; JOENSUU H
      EVALUATION OF RESPONSE TO RADIOTHERAPY IN DEAD-END NECK-CANCER BY POSITRON EMISSION TOMOGRAPHY AND [C-11] METHIONINE

      International journal of radiation oncology, biology, physics
    54. LAPELA M; LESKINENKALLIO S; VARPULA M; GRENMAN S; SALMI T; ALANEN K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; TERAS M; JOENSUU H
      METABOLIC IMAGING OF OVARIAN-TUMORS WITH CARBON-11-METHIONINE - A PETSTUDY

      The Journal of nuclear medicine
    55. LINDHOLM P; LESKINEN S; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; TERAS M; JOENSUU H
      CARBON-11-METHIONINE PET IMAGING OF MALIGNANT-MELANOMA

      The Journal of nuclear medicine
    56. RINNE JO; HUBLIN C; PARTINEN M; RUOTTINEN H; RUOTSALAINEN U; NAGREN K; LEHIKOINEN P; LAIHINEN A
      POSITRON EMISSION TOMOGRAPHY STUDY OF HUMAN NARCOLEPSY - NO INCREASE IN STRIATAL DOPAMINE D-2 RECEPTORS

      Neurology
    57. RINNE JO; KUIKKA J; LAIHINEN A; NAGREN K; LEHIKOINEN P; BERGSTROM K; RUOTSALAINEN U; RUOTTINEN H; RINNE UK
      A COMPARISON OF [I-123] BETA-CIT SPECT AND [C-11] BETA-CIT PET IN IMAGING THE MONOAMINE TRANSPORTERS IN PARKINSONS-DISEASE

      Neurology
    58. LAIHINEN A; RINNE JO; RUOTTINEN H; NAGREN K; LEHIKOINEN P; OIKONEN V; RUOTSALAINEN U; RINNE UK
      DOPAMINE D1 RECEPTORS IN NORMAL AND PARKINSONIAN BRAINS STUDIED WITH [C-11] SCH 39166 AND [C-11] NNC 756

      Neurology
    59. RINNE JO; LAIHINEN A; RUOTTINEN H; RUOTSALAINEN U; NAGREN K; LEHIKOINEN P; OIKONEN V; RINNE UK
      INCREASED DENSITY OF DOPAMINE D2 RECEPTORS IN THE PUTAMEN, BUT NOT INTHE CAUDATE-NUCLEUS IN EARLY PARKINSONS-DISEASE - A PET STUDY WITH [C-11] RACLOPRIDE

      Journal of the neurological sciences
    60. NAGREN K; SCHOEPS KO; HALLDIN C; SWAHN CG; FARDE L
      SELECTIVE SYNTHESIS OF RACEMIC 1-C-11-LABELED NOREPINEPHRINE, OCTOPAMINE, NORPHENYLEPHRINE AND PHENYLETHANOLAMINE USING [C-11] NITROMETHANE

      Applied radiation and isotopes
    61. FARDE L; HALLDIN C; NAGREN K; SUHARA T; KARLSSON P; SCHOEPS KO; SWAHN CG; BONE D
      POSITRON EMISSION TOMOGRAPHY SHOWS HIGH SPECIFIC UPTAKE OF RACEMIC C-11 LABELED NOREPINEPHRINE IN THE PRIMATE HEART

      European journal of nuclear medicine
    62. LAPELA M; LESKINENKALLIO S; JOENSUU H; VARPULA M; GRENMAN S; ALANEN K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; TERAS M; NORDMAN E; WEGELIUS U
      IMAGING OF UTERINE CARCINOMA BY C-11 METHIONINE AND POSITRON EMISSIONTOMOGRAPHY

      The Journal of nuclear medicine
    63. NAGREN K; HALLLDIN C
      IMPROVED SYNTHESIS OF SOME COMMONLY USED PET RADIOLIGANDS

      The Journal of nuclear medicine
    64. LAPELA M; LESKINENKALLIO S; VARPULA M; GRENMAN S; ALANEN K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; TERAS M; JOENSUU H
      IMAGING OF UTERINE CARCINOMA BY CARBON-11-METHIONINE AND PET

      The Journal of nuclear medicine
    65. LINDHOLM P; LESKINENKALLIO S; KIRVELA O; NAGREN K; LEHIKOINEN P; PULKKI K; PELTOLA O; RUOTSALAINEN U; TERAS M; JOENSUU H
      HEAD AND NECK-CANCER - EFFECT OF FOOD INGESTION ON UPTAKE OF C-11 METHIONINE

      Radiology
    66. HIETALA J; SYVALAHTI E; VUORIO K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; RAKKOLAINEN V; LEHTINEN V; WEGELIUS U
      STRIATAL D-2, DOPAMINE-RECEPTOR CHARACTERISTICS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS STUDIED WITH POSITRON EMISSION TOMOGRAPHY

      Archives of general psychiatry
    67. HIETALA J; WEST C; SYVALAHTI E; NAGREN K; LEHIKOINEN P; SONNINEN P; RUOTSALAINEN U
      STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE

      Psychopharmacology
    68. SCHOEPS KO; HALLDIN C; NAGREN K; SWAHN CG; KARLSSON P; HALL H; FARDE L
      PREPARATION OF [1-C-11]DOPAMINE, [1-C-11]P-TYRAMINE AND [1-C-11]M-TYRAMINE - AUTORADIOGRAPHY AND PET EXAMINATION OF [1-C-11]DOPAMINE IN PRIMATES

      Nuclear medicine and biology
    69. LINDHOLM P; LESKINENKALLIO S; MINN H; BERGMAN J; HAAPARANTA M; LEHIKOINEN P; NAGREN K; RUOTSALAINEN U; TERAS M; JOENSUU H; WEGELIUS U; NORDMAN E
      UPTAKE OF 18F-FLUORODEOXYGLUCOSE AND 11C-METHIONINE IN HEAD AND NECK-CANCER

      The Journal of nuclear medicine
    70. LINDHOLM P; LESKINENKALLIO S; MINN H; BERGMAN J; HAAPARANTA M; LEHIKOINEN P; NAGREN K; RUOTSALAINEN U; TERAS M; JOENSUU H
      COMPARISON OF FLUORINE-18-FLUORODEOXYGLUCOSE AND CARBON-11-METHIONINEIN HEAD AND NECK-CANCER

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 15:25:57